Cerus Corporation (NASDAQ:CERS)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for CERS
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
-
DAN: ...
The holdings that are most interesting to me are $NVTA $TXG $VCYT $SHOP $NVDA and $CERS. They all look like they may have more upside from here.
This is my thought: Be open to the possibility that this reversal could have legs. Seasonality is on ... - Hawaiianmaxx: @DAN $ARKK $NVTA $TWOU $U $TXG $VCYT $PACB $TWST $VERV $SHOP $NVDA $CERS $TSLA good read, Sir 👍
- DAN: @Hawaiianmaxx $ARKK $NVTA $TWOU $U $TXG $VCYT $PACB $TWST $VERV $SHOP $NVDA $CERS $TSLA Thank you! ;-)
- Docoof: Massive volume $ARKK winner today: #23 $NVTA +33% with volume = 105.5M (np) [Everything in $ARKK is green except for $SHOP and $CERS — both are down < 1%.]
- Wykeman: $CERS NH Nice volume.
- jr3345: $CERS - CEO on Mad Money tonight. What Cerus does - dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company, deploying and supplying vital technologies and pathogen-protected blood components for blood centers, hospitals and ultimately patients who rely on safe blood. Believe @tnt posted a while back. Long stock & Jul 6 calls
- grinningcat_o3: $CERS breaking out on a squeeze it seems.
- tnt: Trimming $CERS into strength. I like the long term, but I want to lock in profits. Keeping about half
- tnt: Do your own due diligence, but this $CERS could be a big winner lotto bonanza. Fauci talking https://www.cerus.com/Home/default.aspx
- Mikev200: @tnt $CERS Are others here unable to copy inks in here such as this one? I can highlight, but then it reduces the post and cant "copy"?
- Brock: @Mikev200 $CERS some links don't actually show up as hyperlinks. You can still highlight it, even if the message collapses you can still hit CTRL+C, then paste it in a new address bar. Drove me nuts initially too
- Allen: @tnt $CERS Good timing :-)
- Mikev200: @Brock $CERS AHHHHHH THANKS!
- tnt: $CERS is a leader in exactly what Fauci is talking about https://som.uci.edu/news_releases/Convalescent-plasma-emerging-pathogens.asp
- tnt: Dr. Fauci talking positively about convalescent plasma treatment. $CERS is your huckleberry. Beauty of a chart https://www.tradingview.com/chart/CERS/0pG0jFLt-CERS-Dr-Fauci-convalescent-plasma-INO-NVAX-MRNA/
- grinningcat_o3: @tnt $CERS nice closing volume to HOD
- PhilHarmonic: $CERS Took a position @ 5.18 hoping for a bounce off the 200 hour moving average. Tight stop. Sold at at 5.22 for $40.00 profit. Did not want to hold over night.
- Wolf: $CERS Up 11% on blood system test report
- DrScience: $IBB nice volume pushing the Biotechs through the 200 DMA in second day of phase 3 of VS breakout. The 50 DMA starting to turn up, CMF turning positive, and a PPS buy signal on the daily chart. Here are some biotech stocks to research over the weekend, paying special attention to where the stock is and why -- $ARWR $ODT $RARX $RGEN $ZLAB $SRPT $CERS $CLVS $CLDX $CHRS $BLUE $MYRA$ $ALNY $CYTK $ACAD $RGEN $NVTA
- indigo1948: @DrScience $IBB $ARWR $ODT $RARX $RGEN $ZLAB $SRPT $CERS $CLVS $CLDX $CHRS $BLUE $MYRA $ALNY $CYTK $ACAD $NVTA - thanks for the information - I own $ARWR, $CLVS, and $NVTA. Will research the others.
- spmeyers: $CERS short candidate; pretty obvious topping pattern on 1-year chart; looking for reversal at 50-day
- tjv821: $cers has almost triple in 6 months np :(
- greenpatrol: $CERS triggered an inside week and up at 6.85 today. Anyone know about the company?
- Bob E: @greenpatrol $CERS Company Profile Cerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells. The chart looks promising, but it is a biotech so trade it accordingly.
- greenpatrol: @Bob E $CERS Hmmm thanks Bob. I'm trying to give up biotechs after narrowly avoiding the $NKTR debacle.
- tjv821: $cers coming bk from the dead
- woodman: $CERS continues to rise.
- tjv821: @woodman $CERS ty for bringing this bk to my attention
- woodman: @tjv821 $CERS - you are welcome. No position. It just caught my eye. I hadn't looked at it for some time.
- woodman: $CERS - sold for a small profit today up from the 200 day. Hit the 50 day and died.. So much for the #Zika stocks. They all are weak (like the rest of the market and particularly biotechs) despite legislation news yesterday. Baked in, I guess.
- agent99: @woodman $CERS #Zika What legislation news are you talking about?
- woodman: @agent99 $CERS #Zika Agreement on funding: http://abcnews.go.com/Politics/wireStory/pelosi-aide-deal-speaker-ryan-covers-flint-aid-42413387
- agent99: @woodman $CERS #Zika Thanks
- woodman: $CERS - just maybe. Long already, but need a close above the 8dEMA. One step at a time.
- woodman: @champ $XON $INO I agree with you, champ. The stocks have pulled back and/or are at relatively low spots on the charts. Same for $CERS.
- woodman: $CERS I had this in my sights, even tried it, but soon sold after buying and moved to sidelines. Today it's collapsing.
- Alexandra: @woodman $CERS Woodman, what other biotechs are up for FDA approval in the near future ? I'll use part of this $SRPT money as mad biotech basket money.
- mopick: @Alexandra $CERS $SRPT Wow, you're really tempting fate with that proposed move. Or, you've got a whole lot more nerve than I do! I totally stay away from small biotech stocks. As Woodman will attest, I also learned a painful lesson. Consider yourself fortunate on the $SRPT.
- Alexandra: @mopick $CERS $SRPT It's the houses money I will be using so no worries. Life rewards the bold said someone smart a long time ago.
- gwenzee: @Alexandra $CERS $SRPT Which house? Remember charity begins at home.
- woodman: @Alexandra $CERS $SRPT As long as you are modest with the $$ you throw at them and realize the stakes, it's fine. They are very risky. Stay on top of catalysts and risk only what won't make you sick if you lose it. You are concerning me a little. Don't get cocky and reckless.
- woodman: @Alexandra $CERS $SRPT - re FDA approval dates and other catalyst dates such as trial data announcements, bookmark this site and explore and use it liberally. http://biopharmcatalyst.com/
- woodman: @champ $XON $INO #Zika Interesting. My $OSUR turned around. Still down today but a hammer. $CERS, which I never bought, has a fairly long tail too.
- woodman: @champ $XON $INO #Zika I took a flier on $CERS to go with my $OSUR.
- champ: @woodman $XON $INO $CERS $OSUR #Zika -- Good Luck!
- woodman: @woodman $XON $INO $CERS $OSUR #Zika Same to you and thanks for your post!!
- woodman: $CERS - potential Zika play on the funding legislation that still has a chance of being passed (I actually tend to think it will get passed, but I could just be an idiot). It's about as low risk as you can get with this particular stock. (Caveat:. Low risk does not necessarily mean high chance of success).
- woodman: $CERS - barely took my stop out and moved back up to close above the 200 day.
- woodman: @champ $XON $INO - I'm in $CERS (low risk buy today) and $OSUR for Zika. Good luck to us both!
- champ: @woodman $XON $INO $CERS $OSUR - They all should work ...whenever they pass the funding bill...Good Luck to You!
- gwenzee: @woodman @champ $XON $INO $CERS $OSUR I have a question. Isn't there an "emergency" acct. someplace that would fund this type of situation so that asking for the passage of a funding bill wouldn't be necessary. It seems to me the only thing that they want is to further pad another government agency. Would love to hear you comments.
- champ: @woodman @TunaHelper @ rck89 $XON $INO $CERS $OSUR - I took a look at this stock $OSUR and I just don't know about this stock for a Zika trade....maybe the two words that you used... is right on up until now ....has been....I don't really know. Howev ...
- rck89: @champ $XON $INO $CERS $OSUR #1 #2 #3 #4 Mmm? Doubtless we all now, the Zika funding bill failed in Congress. But $OSUR is up a tad. Good sign for the stock?
- champ: @rck89 $XON $INO $CERS $OSUR #1 #2 #3 #4 - It was all over the News this morning in the pre-market....they are working on the wording and the repbulican want to drag the funds from other health funds...they are saying that their is a lot of Ebola money just sitting their not being used and all of this will be worked out ....but thats the whole point for me... because it will pass ....went our really smart leaders in DC stop all the BS and get to work. I'm not going to be the one of the ones hat says I missed this trade. This stock is loaded and ready for a big bounce.... is my guess.
- TunaHelper: @champ $XON A couple other Zika tickers: $INO and $CERS
- woodman: @TunaHelper @champ $XON $INO $CERS - The Zika-related stock to be in has been $OSUR
- rck89: @woodman $XON $INO $CERS $OSUR So is it too late for $OSUR?
- TunaHelper: @woodman $XON $INO $CERS $OSUR Didn't know about that one. Thank you @woodman!
- champ: @woodman $XON $INO $CERS $OSUR - On $OSUR this is the first that I hear of this stock being a related Zika stock. I see now that they received a contract on 8/23 and that news bounced the stock.... on that contract news of $16.6 from the US Dept of Health on a Zika test. Thanks.... I will check it out. I saw you post about $OSUR and Ebola on 10/16 but I did not read it... I guess I should have.
- woodman: @rck89 $XON $INO $CERS $OSUR - Great question. I watched it go up without pulling the trigger. It's taking a rest now. What happens next I don't know. It's rather extended (it's trading even above the 5dEMA and is way above the 50 and 200dSMA), but is now flagging.
- rck89: @woodman $XON $INO $CERS $OSUR Thanks...think I'll wait a bit before pulling the triggers. I'll feel better if it holds its 200 dma.
- trader123: $BCRX- breaking out on higher volume! One of the Zika favorites $INO, $CERS, $CEMI, $NLNK. Bio stocks acting well today, any specific news on $BCRX? Long $BCRX @ $4.11 Thank you!
- tjv821: $cers anyone in this??
- Aragorn: $CERS Rev Strat variation inside day they took it don now higher than there previous days close to and inside day and up bullish engulfer. A ZIKA play popped the other day and pulled back to the 8ena today went as low as the 21 ready for the next leg up
- glens13: @Aragorn $CERS - I like it - most important part of the earnings transcript was this " They were awarded up to $181million - 5year contract from BARDA for their Intercept System" Revenue for the quarter was $9.25 million. If u take $181/5 years = 36.2 million per year / 4 quarters = 9.05 million - which in my view would be approximately 100% revenue growth.
- glens13: $CERS - new article just released - keeping a close eye www.newscientist.com/article/2099798
- Eurobob: @TIPPYTWO $CERS I know what the do, I've owned the stock for several week, and did not say it was a zika drug maker, I clearly stated it was a zika play, which is based on the blood cleaning system
- janner0814: #DANG! #niceENTRY on $CERS @EuroBob! Weekly chart.... well above the BB. Advantageous price entry trumps all. CAVEAT: It's clearly Extended... however, #BIOTECHS can remain extended for given periods. Too bad for me, it's a #BIO and <$20. #MELIKEY the chart, but not the #SECTOR. NP.
- TIPPYTWO: @Eurobob...suggest you reread my comment as they were directed to GLENS13 posting who referred to $CERS as a "Zika virus drug maker". ..not you!
- Eurobob: $CERS zika play, breaking nicely out of an ascending channel, and over 2 yr resistance...heading for the 5 yr resistance at 8, and if it gets over this, could be lots of upside, particularly if zika spreads around the gulf coast
- glens13: $CERS - zika virus drug maker - coming out of VS. Dan your thoughts -
- TIPPYTWO: @glens13 $CERS Suggest you research $CERS a bit more...it is not a zika drug maker....it is a biomedical products company whose focus is developing and commercializing the INTERCEPT blood system to enhance blood safety.
- steve71: $CERS Adding @ 6.10. Holding it's own in a weak market. Cerus makes systems for sterilizing blood products. As Zika seems to be spreading, demand is increasing.
- issues: @steve71 $CERS yeah looks great!
- champ: @captron $XON - The bill is for an anti-virus...no one has one yet as far as i know. Here are others that could be in play....$INO $CERS $SNY $TKPYT $GSK $APT and we all no about $LAKE. I picked $XON last week.
- steve71: $ILMN $CERS Illumina is behaving well, as though the earnings crash was too extreme. If it fills half of the gap down, that would be 156, just below the 50 dma. A reasonable trading target. Cerus continues to climb, Zika powered. They should thrive as more blood banks worldwide embrace their sterilization technology. Cerus is able to treat platelet and plasma transfusions now. They are working on approval for red cell transfusions, a 10X larger market.
- steve71: $ACAD $AKRX $ILMN $CERS Adds at the close.
- steve71: $CERS Biotech is soft today, but $CERS is moving. The Zika story has helped. Blood supply safety is a big concern. Cerus has an FDA approved, UV based method for sterilizing platelet transfusions and plasma. It apparently preserves platelet function better than the old gamma radiation method. Prevents RNA replication in bacteria, viruses, other pathogens and donor white cells. Adoption by blood banks started slowly, but is accelerating. U.S. and international sales. The chart is in a two year uptrend, but volatile.
- tjv821: $cers anyone liking it here?
- DAN: @tjv821 $cers I'm not really warming up to this. The technical picture is really muddled and sloppy, and the stock is up at the prior highs. Seems like there would have to be some kind of news or company announcement to push the stock out of the range. EArnings are estimated to be released sometime between May 3-9th.
- tjv821: $cers looking strong
- tjv821: $CERS jumping after earnings on increasing CMF and trading volume
- pcotton: Scan results today 3/3 - high opening-volume intraday stalwarts: $CERS $CHK $DEPO $EEFT $ELS $JOY $NFG $NRE $ODFL $QLIK
- StockMarketMentor: A Price Alert has been triggered for $CERS Cerus Corporation. Click here to view associated video clip: http://stockmarketmentor.com/stockanalysis.html?ticker=CERS&clip=64118
- tjv821: $cers anyone else in this??
- Aragorn: $CERS still moving up on the daily
- Aragorn: $MYGN $CERS here are 2 ideas . MYGN breaking out of a flag. CERS moving up the 8ema setting up for a measured move up
- DCorion: @Aragorn $MYGN $CERS I appreciate your many ideas. Also been watching $ABC. Looks to be setting up above the 50 day and trying poke thru the 200 day and in VS.
- Aragorn: @DCorion $MYGN $CERS $ABC I was surprised when this broke below the 50 at the 112 area. I was very positive that this would hold up and even posted about that when someone asked about the stock. I felt the same about $MCK. ABC is rebounding more than MCK. Yes ABC looks good lets see in 5 bucks what happens at the 200 but we have positive MACD and BOP a possible tell on future moves has been positive showing large orders on the buy side 5 dollars ago so maybe institutions are getting behind this. I have no position and thanks for sharing with the forum.
- ogas: @Aragorn $MYGN $CERS How are you calculating your measured move?
- Dave: @woodman - Thanks for the news on that, folks. Here's some good charts that showed up in my Biotech folder today (many are on the verge of breakouts and very consistent moves on the hourly): $VVUS (mild inverse H&S), $RGLS, $ZGNX, $AMRN, $RPTP holding the 200, $OHRP, $SRNE, $FPRX, $CBLI (rounded bottom breakout, RBB), $LXRX, $INCY, $CERS, $STEM and $NKTR.
- steve71: $PTLA $CERS $IPCI This trio of small biotechs continues to defy the trend.
- steve71: $CERS $IPCI $ACAD $PTLA $TRIB and $REGN Several of the small cap biotechs, and Regeneron, are again outperforming. None of these are in the CAR-T space. Interesting because there's no common research theme. Maybe it implies that investors don't see growth in other industries, so they're willing to take some risk here. Biotechs and banks.
- DrChucky: $CERS - up 14% to 4.70. an extremely strong day on nice volume, no particular news. earnings may 5
- DrChucky: $CERS - small cap biotech smashdown.
- markcomish: $CERS $JUNO $KITE $CEMP $CMRX $ATRS $SSH Many of the Biotechs are presenting at the Cowen and Company 35th Annual Health Care Conference next week. Do any of our forum experts have any opinions on weather this conference will spark much big news?
- Kokomo2: $CERS in a vol squeeze and reports earnings tomorrow after the bell; Yahoo! reports short interest at 21.7%; no position yet.
- DrChucky: $CERS - inked a second deal with another blood bank for its INTERCEPT system. looks like this might be a better catalyst than yesterdays news. Bids are at 5.50 in pre market, ask at 5.75. This could pop. long.
- DrChucky: @lostsheep - $CERS added a bit at 5.54.
- steve71: $CERS Last week we spoke of Cerus. Today it announced that a Chesapeake region blood bank has signed a 3 year agreement for their Intercept technology to purify platelet transfusions. Cerus jumped to $7.00 on 12/2014 FDA approval. Then it fell to $5.00 after a large secondary priced at $5.50. $5.50 has been recent resistance, but it's itching to break through.
| Stock Price | $1.58 |
| Change | 0.00% |
| Volume | 2,375,350 |
Cerus Corporation is a biomedical products company, which focuses on commercializing the INTERCEPT Blood System to enhance blood safety.
Request Video of CERSAlready a member? Sign in here.
Past Month
Leading Peers
-
$8.10 261.95%
-
$9.45 124.91%
-
$16.98 106.56%
Past Month
Lagging Peers
-
$9.73 %
-
$17.03 -115.10%
-
$35.42 -44.96%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!